303 related articles for article (PubMed ID: 33980289)
1. Identification of prognosis-related molecular subgroups based on DNA methylation in pancreatic cancer.
Yin X; Kong L; Liu P
Clin Epigenetics; 2021 May; 13(1):109. PubMed ID: 33980289
[TBL] [Abstract][Full Text] [Related]
2. Identification of DNA methylation-driven genes and construction of a nomogram to predict overall survival in pancreatic cancer.
Deng GC; Sun DC; Zhou Q; Lv Y; Yan H; Han QL; Dai GH
BMC Genomics; 2021 Nov; 22(1):791. PubMed ID: 34732125
[TBL] [Abstract][Full Text] [Related]
3. Establishment and validation of a prognostic nomogram based on a novel five-DNA methylation signature for survival in endometrial cancer patients.
Li X; Yin F; Fan Y; Cheng Y; Dong Y; Zhou J; Wang Z; Li X; Wang J
Cancer Med; 2021 Jan; 10(2):693-708. PubMed ID: 33350104
[TBL] [Abstract][Full Text] [Related]
4. Identification and Validation of Constructing the Prognostic Model With Four DNA Methylation-Driven Genes in Pancreatic Cancer.
Chen G; Long J; Zhu R; Yang G; Qiu J; Zhao F; Liu Y; Tao J; Zhang T; Zhao Y
Front Cell Dev Biol; 2021; 9():709669. PubMed ID: 35087823
[No Abstract] [Full Text] [Related]
5. Genome-wide DNA methylation analysis reveals molecular subtypes of pancreatic cancer.
Mishra NK; Guda C
Oncotarget; 2017 Apr; 8(17):28990-29012. PubMed ID: 28423671
[TBL] [Abstract][Full Text] [Related]
6. A novel natural killer cell-related signatures to predict prognosis and chemotherapy response of pancreatic cancer patients.
Lan Y; Jia Q; Feng M; Zhao P; Zhu M
Front Genet; 2023; 14():1100020. PubMed ID: 37035749
[No Abstract] [Full Text] [Related]
7. Identification of a methylomics-associated nomogram for predicting overall survival of stage I-II lung adenocarcinoma.
Wang H; Wei C; Pan P; Yuan F; Cheng J
Sci Rep; 2021 May; 11(1):9938. PubMed ID: 33976305
[TBL] [Abstract][Full Text] [Related]
8. SLCO4C1 promoter methylation is a potential biomarker for prognosis associated with biochemical recurrence-free survival after radical prostatectomy.
Li X; Zhang W; Song J; Zhang X; Ran L; He Y
Clin Epigenetics; 2019 Jul; 11(1):99. PubMed ID: 31288850
[TBL] [Abstract][Full Text] [Related]
9. Molecular subtypes based on DNA methylation predict prognosis in colon adenocarcinoma patients.
Yang C; Zhang Y; Xu X; Li W
Aging (Albany NY); 2019 Dec; 11(24):11880-11892. PubMed ID: 31852837
[TBL] [Abstract][Full Text] [Related]
10. A novel DNA methylation signature to improve survival prediction of progression-free survival for testicular germ cell tumors.
Gao F; Xu Q; Jiang Y; Lu B
Sci Rep; 2023 Mar; 13(1):3759. PubMed ID: 36882567
[TBL] [Abstract][Full Text] [Related]
11. Construction of a novel model based on cell-in-cell-related genes and validation of KRT7 as a biomarker for predicting survival and immune microenvironment in pancreatic cancer.
Song J; Ruze R; Chen Y; Xu R; Yin X; Wang C; Xu Q; Zhao Y
BMC Cancer; 2022 Aug; 22(1):894. PubMed ID: 35974300
[TBL] [Abstract][Full Text] [Related]
12. A novel methylation signature predicts inferior outcome of patients with PDAC.
Gu M; Sun J; Zhang S; Chen J; Wang G; Ju S; Wang X
Aging (Albany NY); 2021 Jan; 13(2):2851-2863. PubMed ID: 33550277
[TBL] [Abstract][Full Text] [Related]
13. Screening of Methylation Gene Sites as Prognostic Signature in Lung Adenocarcinoma.
Dong M; Yang Z; Li X; Zhang Z; Yin A
Yonsei Med J; 2020 Dec; 61(12):1013-1023. PubMed ID: 33251775
[TBL] [Abstract][Full Text] [Related]
14. A Prognostic Prediction Model Developed Based on Four CpG Sites and Weighted Correlation Network Analysis Identified
Kong L; Liu P; Fei X; Wu T; Wang Z; Zhang B; Li J; Tan X
Front Oncol; 2020; 10():1716. PubMed ID: 32984053
[TBL] [Abstract][Full Text] [Related]
15. Precision oncology: Artificial intelligence, circulating cell-free DNA, and the minimally invasive detection of pancreatic cancer-A pilot study.
Bahado-Singh RO; Turkoglu O; Aydas B; Vishweswaraiah S
Cancer Med; 2023 Oct; 12(19):19644-19655. PubMed ID: 37787018
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of 3-CpG methylation prognostic signature based on different survival indicators for colorectal cancer.
Huang H; Zhang L; Fu J; Tian T; Liu X; Liu Y; Sun H; Li D; Zhu L; Xu J; Zheng T; Jia C; Zhao Y
Mol Carcinog; 2021 Jun; 60(6):403-412. PubMed ID: 33826760
[TBL] [Abstract][Full Text] [Related]
17. DNA methylation profiling to predict recurrence risk in stage Ι lung adenocarcinoma: Development and validation of a nomogram to clinical management.
Ma X; Cheng J; Zhao P; Li L; Tao K; Chen H
J Cell Mol Med; 2020 Jul; 24(13):7576-7589. PubMed ID: 32530136
[TBL] [Abstract][Full Text] [Related]
18. DNA methylation data-based molecular subtype classification related to the prognosis of patients with cervical cancer.
Li C; Ke J; Liu J; Su J
J Cell Biochem; 2020 Mar; 121(3):2713-2724. PubMed ID: 31680300
[TBL] [Abstract][Full Text] [Related]
19. DNA methylation patterns-based subtype distinction and identification of soft tissue sarcoma prognosis.
Li K; Wu Z; Yao J; Fan J; Wei Q
Medicine (Baltimore); 2021 Feb; 100(5):e23787. PubMed ID: 33592836
[TBL] [Abstract][Full Text] [Related]
20. Prediction of survival and recurrence in patients with pancreatic cancer by integrating multi-omics data.
Baek B; Lee H
Sci Rep; 2020 Nov; 10(1):18951. PubMed ID: 33144687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
